{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:51:51Z","timestamp":1770504711858,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.psyneuen.2005.08.010","type":"journal-article","created":{"date-parts":[[2005,9,29]],"date-time":"2005-09-29T07:16:43Z","timestamp":1127978203000},"page":"340-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia"],"prefix":"10.1016","volume":"31","author":[{"given":"Deanna L.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert R.","family":"Conley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.psyneuen.2005.08.010_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0920-9964(01)00321-8","article-title":"Bone mineral density and prolactin associations in patients with chronic schizophrenia","volume":"59","author":"Abraham","year":"2003","journal-title":"Schizophr Res."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib2","first-page":"137","article-title":"Sexual dysfunction in male schizophrenic patients","volume":"56","author":"Aizenberg","year":"1995","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4088\/JCP.v62n07a07","article-title":"Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine","volume":"62","author":"Aizenberg","year":"2001","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib4","first-page":"134","article-title":"Schizophrenia and sexuality: a report of twelve unusual cases-part I","volume":"41","author":"Akhtar","year":"1980","journal-title":"J. Clin. Psychiatry."},{"issue":"4","key":"10.1016\/j.psyneuen.2005.08.010_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0006-3223(97)00190-X","article-title":"Study Group, Multiple fixed doses of Seroquel (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo","volume":"42","author":"Arvenitis","year":"1997","journal-title":"Biol. Psychiatry."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/070674370404900504","article-title":"New antipsychotics, compliance, quality of life and subjective tolerability-are patients better off?","volume":"49","author":"Awad","year":"2004","journal-title":"Can. J. Psychiatry."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/713847170","article-title":"Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study","volume":"29","author":"Bobes","year":"2003","journal-title":"J. Sex. Marital. Ther."},{"issue":"2","key":"10.1016\/j.psyneuen.2005.08.010_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004714-199604000-00008","article-title":"ICI 204,636, An atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia","volume":"16","author":"Borison","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1043-6618(03)00174-9","article-title":"Risperidone-associated Hyperprolactinemia: evaluation in twenty psychiatric outpatients","volume":"48","author":"Brunellsechi","year":"2003","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.psyneuen.2005.08.010_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1176\/appi.ps.52.5.631","article-title":"Case management and assertive community treatment in Europe","volume":"52","author":"Burns","year":"2001","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib11","first-page":"397","article-title":"Assessment of paroxetine-induced sexual dysfunction using the changes in sexual functioning questionnaire","volume":"31","author":"Clayton","year":"1995","journal-title":"Psychopharmacol Bull."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib12","unstructured":"Conley RR, Kelly DL, Nelson M, Richardson CM, Feldman S, Reynolds R, Steiner P, Yu Y, Khan I, McMullen R, Gale E, Mackowick M, Love R, December 2003. Risperidone and quetiapine vs. fluphenazine in treatment-resistant schizophrenia. Presented at the American College of Neuropsychopharmacology (ACNP), San Juan, Puerto Rico."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0306-4530(02)00113-0","article-title":"Sexual dysfunction and antipsychotic treatment","volume":"28","author":"Cutler","year":"2003","journal-title":"Psychoneuroendocrinology."},{"issue":"1","key":"10.1016\/j.psyneuen.2005.08.010_bib14","first-page":"66","article-title":"Assessment of Capacity to give consent to research participation: state-of-the-art and beyond","volume":"1","author":"DeRenzo","year":"1998","journal-title":"J. Health Care Law Policy."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1017\/S1461145704005012","article-title":"Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation","volume":"8","author":"Dossenbach","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"supp 89","key":"10.1016\/j.psyneuen.2005.08.010_bib16","first-page":"11","article-title":"Compliance with antipsychotic drug treatment: influence of side effects","volume":"89","author":"Fleischhacker","year":"1994","journal-title":"Acta Psychiatr Scand."},{"issue":"8","key":"10.1016\/j.psyneuen.2005.08.010_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00005053-198208000-00004","article-title":"Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic patients","volume":"170","author":"Ghadirian","year":"1982","journal-title":"J. Nerv Ment Dis."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib17","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced Hyperprolactinemia: mechanisms, clinical features and management","volume":"64","author":"Haddad","year":"2004","journal-title":"Drugs."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.57.6.553","article-title":"A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy","volume":"57","author":"Kapur","year":"2000","journal-title":"Arch Gen Psychiatry."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/oxfordjournals.schbul.a007130","article-title":"Sexuality and schizophrenia: a review","volume":"30","author":"Kelly","year":"2005","journal-title":"Schizophrenia Bulletin."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s002130050603","article-title":"A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia","volume":"137","author":"King","year":"1998","journal-title":"Psychopharmacology."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00004714-199902000-00011","article-title":"Prolactin levels and adverse events in patients treated with risperidone","volume":"19","author":"Kleinberg","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0306-4530(02)00130-0","article-title":"What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning","volume":"28","author":"Knegtering","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2005.08.010_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/01.jcp.0000106220.36344.04","article-title":"A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning","volume":"24","author":"Knegtering","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.eurpsy.2004.06.031","article-title":"Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence","volume":"19","author":"Lambert","year":"2004","journal-title":"Eur. Psychiatry."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1037\/h0095323","article-title":"The sexual education needs of those disabled by mental illness","volume":"21","author":"Lewis","year":"1997","journal-title":"Psychiatric Rehabilitation J."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1192\/bjp.182.1.50","article-title":"Nithsdale,Schizophrenia surveys 24: sexual dysfunctions. Case control study","volume":"182","author":"Macdonald","year":"2003","journal-title":"Br. J. Psychiatry."},{"issue":"suppl 28","key":"10.1016\/j.psyneuen.2005.08.010_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/00926230252851276","article-title":"Validated instruments for assessing female sexual function","volume":"1","author":"Meston","year":"2002","journal-title":"J. Sex Marital Ther."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.jcp.0000150223.31007.e0","article-title":"Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?","volume":"25","author":"O'Keane","year":"2005","journal-title":"J. Clin. Psychopharmacol"},{"key":"10.1016\/j.psyneuen.2005.08.010_bib30","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4088\/JCP.v63n1206","article-title":"Predictors of noncompliance in patients with schizophrenia","volume":"63","author":"Perkins","year":"2002","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib31","series-title":"Sexual pharmacology","first-page":"114","article-title":"Evaluation of drug effects on human sexual dysfunction","author":"Riley","year":"1993"},{"key":"10.1016\/j.psyneuen.2005.08.010_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01.jcp.0000125684.82219.53","article-title":"Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice: a naturalistic compartive study","volume":"24","author":"Ritsner","year":"2004","journal-title":"J. Clin. Psyhcopharmacol."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib33","first-page":"318","article-title":"Some implications of sexual activity for mental illness","volume":"55","author":"Rozan","year":"1971","journal-title":"Mental Hygiene."},{"issue":"6","key":"10.1016\/j.psyneuen.2005.08.010_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/archpsyc.1997.01830180067009","article-title":"Quetiapine in patients with schizophrenia: a high- and low-dose double-blind comparison with placebo","volume":"54","author":"Small","year":"1997","journal-title":"Arch Gen Psychiatry."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1192\/bjp.181.1.49","article-title":"Sexual dysfunction in patients taking conventional antipsychotic medication","volume":"181","author":"Smith","year":"2002","journal-title":"Br. J. Psychiatry."},{"issue":"3 suppl 1","key":"10.1016\/j.psyneuen.2005.08.010_bib35","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/01.jcp.0000084035.22282.31","article-title":"Effects of antipsychotics on sexual and endocrine function in women: implications for clinical practice","volume":"23","author":"Smith","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib37","first-page":"1238","article-title":"Sexual side effects of antipsychotic mediation: evaluation and interventions","volume":"41","author":"Sullivan","year":"1990","journal-title":"Hospital Community Psychiatry."},{"key":"10.1016\/j.psyneuen.2005.08.010_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1176\/appi.ajp.159.1.133","article-title":"Elevation of prolactin levels by atypical antipsychotics","volume":"159","author":"Turrone","year":"2002","journal-title":"Am. J. Psychiatr."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453005001885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453005001885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:26:47Z","timestamp":1759681607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453005001885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0306453005001885"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2005.08.010","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2005.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}